328 related articles for article (PubMed ID: 30857452)
1. Prognostic Importance of Defibrillator-Appropriate Shocks and Antitachycardia Pacing in Patients With Mild Heart Failure.
Biton Y; Daimee UA; Baman JR; Kutyifa V; McNitt S; Polonsky B; Zareba W; Goldenberg I
J Am Heart Assoc; 2019 Mar; 8(6):e010346. PubMed ID: 30857452
[TBL] [Abstract][Full Text] [Related]
2. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).
Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP
Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
[TBL] [Abstract][Full Text] [Related]
4. Novel ICD Programming and Inappropriate ICD Therapy in CRT-D Versus ICD Patients: A MADIT-RIT Sub-Study.
Kutyifa V; Daubert JP; Schuger C; Goldenberg I; Klein H; Aktas MK; McNitt S; Stockburger M; Merkely B; Zareba W; Moss AJ
Circ Arrhythm Electrophysiol; 2016 Jan; 9(1):e001965. PubMed ID: 26743237
[TBL] [Abstract][Full Text] [Related]
5. Survival After Implantable Cardioverter-Defibrillator Shocks.
Aktaş MK; Younis A; Zareba W; Kutyifa V; Klein H; Daubert JP; Estes M; McNitt S; Polonsky B; Goldenberg I
J Am Coll Cardiol; 2021 May; 77(20):2453-2462. PubMed ID: 34016257
[TBL] [Abstract][Full Text] [Related]
6. Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device.
Richardson TD; Hale L; Arteaga C; Xu M; Keebler M; Schlendorf K; Danter M; Shah A; Lindenfeld J; Ellis CR
J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29475875
[TBL] [Abstract][Full Text] [Related]
7. Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial.
Lee AY; Kutyifa V; Ruwald MH; McNitt S; Polonsky B; Zareba W; Moss AJ; Ruwald AC
Heart Rhythm; 2015 Sep; 12(9):2010-7. PubMed ID: 26025322
[TBL] [Abstract][Full Text] [Related]
8. Reassessing the role of antitachycardia pacing in fast ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: Results from MADIT-RIT.
Schuger C; Daubert JP; Zareba W; Rosero S; Yong P; McNitt S; Kutyifa V
Heart Rhythm; 2021 Mar; 18(3):399-403. PubMed ID: 33232811
[TBL] [Abstract][Full Text] [Related]
9. Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-Are there predictors of appropriate therapy?
Weissler-Snir A; Dorian P; Rakowski H; Care M; Spears D
Heart Rhythm; 2021 Jan; 18(1):63-70. PubMed ID: 32800967
[TBL] [Abstract][Full Text] [Related]
10. Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy).
Ruwald MH; Abu-Zeitone A; Jons C; Ruwald AC; McNitt S; Kutyifa V; Zareba W; Moss AJ
J Am Coll Cardiol; 2013 Oct; 62(15):1343-50. PubMed ID: 23770172
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
[TBL] [Abstract][Full Text] [Related]
12. Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
Aktas MK; Huang DT; Daubert JP; Schuger CD; McNitt S; Goldenberg I; Moss AJ; Zareba W
Heart Rhythm; 2013 Feb; 10(2):193-9. PubMed ID: 23085128
[TBL] [Abstract][Full Text] [Related]
13. Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT.
Sood N; Ruwald AC; Solomon S; Daubert JP; McNitt S; Polonsky B; Jons C; Clyne CA; Zareba W; Moss AJ
Eur Heart J; 2014 Jan; 35(2):106-15. PubMed ID: 24179073
[TBL] [Abstract][Full Text] [Related]
14. Association of Antitachycardia Pacing or Shocks With Survival in 69,000 Patients With an Implantable Defibrillator.
Strickberger SA; Canby R; Cooper J; Coppess M; Doshi R; John R; Connolly AT; Roberts G; Karst E; Daoud EG
J Cardiovasc Electrophysiol; 2017 Apr; 28(4):416-422. PubMed ID: 28128491
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Outcomes Among a Nationwide Cohort of Patients Using an Implantable Cardioverter-Defibrillator: UMBRELLA Study Final Results.
Briongos-Figuero S; García-Alberola A; Rubio J; Segura JM; Rodríguez A; Peinado R; Alzueta J; Martínez-Ferrer JB; Viñolas X; Fernández de la Concha J; Anguera I; Martín M; Cerdá L; Pérez L;
J Am Heart Assoc; 2021 Jan; 10(1):e018108. PubMed ID: 33356406
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of ventricular tachyarrhythmias in patients treated with CRT-D.
Kutyifa V; Klein HU; Wang PJ; McNitt S; Polonsky B; Zima E; Merkely B; Moss AJ; Zareba W
Heart Rhythm; 2013 Jul; 10(7):943-50. PubMed ID: 23639624
[TBL] [Abstract][Full Text] [Related]
17. Comparison of age (<75 Years versus ≥75 Years) to risk of ventricular tachyarrhythmias and implantable cardioverter defibrillator shocks (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
Aktas MK; Goldenberg I; Moss AJ; Huang DT; Kutyifa V; Wang PJ; Brenyo A; McNitt S; Zareba W; Barsheshet A
Am J Cardiol; 2014 Dec; 114(12):1855-60. PubMed ID: 25438913
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial.
Knops RE; van der Stuijt W; Delnoy PPHM; Boersma LVA; Kuschyk J; El-Chami MF; Bonnemeier H; Behr ER; Brouwer TF; Kääb S; Mittal S; Quast ABE; Smeding L; Tijssen JGP; Bijsterveld NR; Richter S; Brouwer MA; de Groot JR; Kooiman KM; Lambiase PD; Neuzil P; Vernooy K; Alings M; Betts TR; Bracke FALE; Burke MC; de Jong JSSG; Wright DJ; Jansen WPJ; Whinnet ZI; Nordbeck P; Knaut M; Philbert BT; van Opstal JM; Chicos AB; Allaart CP; Borger van der Burg AE; Clancy JF; Dizon JM; Miller MA; Nemirovsky D; Surber R; Upadhyay GA; Weiss R; de Weger A; Wilde AAM; Olde Nordkamp LRA;
Circulation; 2022 Feb; 145(5):321-329. PubMed ID: 34779221
[TBL] [Abstract][Full Text] [Related]
19. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.
Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I
Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186
[TBL] [Abstract][Full Text] [Related]
20. Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial.
Ruwald MH; Zareba W; Jons C; Zhang C; Ruwald AC; Olshansky B; McNitt S; Bloch Thomsen PE; Shoda M; Merkely B; Moss AJ; Kutyifa V
Circulation; 2013 Aug; 128(7):694-701. PubMed ID: 23881862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
